Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pain, Postoperative 18Breast Neoplasms 14Pain 5Lung Neoplasms 5Neoplasms 3Agnosia 3Thyroid Nodule 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Goiter 2Colorectal Neoplasms 2Chronic Pain 2Breast Cancer Female 2Abdominal Cancer 2post laminectomy syndrome 1Uterine Cervical Dysplasia 1Supratentorial Neoplasms 1Stomach Neoplasms 1Respiration Disorders 1Reperfusion Injury 1Rectal Neoplasms 1Prostatic Neoplasms 1Peritoneal Cancer 1Neuroma 1Neuralgia 1Mucositis 1Liver Neoplasms 1Leiomyoma 1Laryngeal Neoplasms 1

Interventions

exemestane 1Tamoxifen 1Pharmacogenomic Variants 1Metformin 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Immunohistochemistry 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endometrial Hyperplasia × Bupivacaine × Clear all
NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Tufts Medical Center

Phase 3 Completed
15 enrolled
Gynecologic

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡